Skip to main content

Ongoing FDAEvent 99828 (8 days ago)

Mindray Patient Monitors and Telemetry Monitoring Systems

The ePM Series Patient Monitor has manual descriptions that may be insufficient or require clarification regarding alarm functions.

Low risk

Using it is unlikely to cause health problems.

FDA Class III recall · How risk is rated

What to do

What happened

Mindray DS USA, Inc. began a recall on August 31, 2026, for certain patient monitors because operator's manuals contain descriptions that may be insufficient or may require clarification regarding selected physiological alarm functions. The recall was added to the FDA's Enforcement Report and classified on October 7, 2026.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

8 products

Compare these product details with yours, then check the recall notice for any restrictions.

  1. Panorama and Telemetry Monitoring System. Operator's Manuals: TMS-6016/Panorama Telepack-608/TMS60 (TD60).

  2. Passport Series Patient Monitor. Operator's Manuals: 8 / 12 / 12M / 17M / V

  3. BeneVision N1 and N-Series Patient Monitor. Patient Monitor: N12/N15/N17/N19/N22.

  4. T1 Patient Monitor. Operator's Manual: T1 Patient Monitor

  5. ePM Series Patient Monitor. Patient Monitor Series: ePM 10M/ePM 12M/ePM 12MA/ ePM 15M/ePM 10A

  6. BeneView Series. Operator's Manuals: T5 / T8

  7. BeneVision Series Telemetry Monitor. Operator's Manuals: TM70/TM80

  8. cPM Series Patient Monitor. Operator's Manual: cPM 8/cPM 12

Details

Company began the recall
Event ID
99828
Company
Mindray DS USA, Inc.
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

Summary by Recall Canary, written with AI · summary updated Oct 8, 2026 · primary source: U.S. Food and Drug Administration